ERNA insider transactions
Ernexa Therapeutics Inc. (ERNA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ERNA
- Large owner Cherington Charles bought $2,000,000 worth of shares (4,000,000 units at $0.50), increasing direct ownership by 144% to 6,779,440 units (SEC Form 4)4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
- Sr. VP of Finance Gurrola Sandra M converted options into 30 shares, increasing direct ownership by 38% to 110 units (SEC Form 4)4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
- Large owner Cherington Charles bought $2,221,826 worth of shares (21,241,163 units at $0.10), increasing direct ownership by 104% to 41,659,743 units (SEC Form 4)4 - Ernexa Therapeutics Inc. (0000748592) (Issuer)
- Amendment: Large owner Cherington Charles bought 13,252,112 shares, increasing direct ownership by 2,381% to 13,808,577 units (SEC Form 4)4/A - Ernexa Therapeutics Inc. (0000748592) (Issuer)
- Large owner Cherington Charles bought $394,174 worth of shares (3,768,397 units at $0.10), increasing direct ownership by 23% to 20,401,602 units (SEC Form 4)4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Wexler William A.4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Sr. VP of Finance Gurrola Sandra M4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Bristol James Arthur4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Cicala Peter4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by President & CEO Luther Sanjeev4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Director Ratner Elena4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 3 filed by new insider Ratner Elena3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- Large owner Cherington Charles bought 13,252,112 shares and converted options into 2,819,546 shares, increasing direct ownership by 2,888% to 16,628,123 units (SEC Form 4)4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- Sr. VP of Finance Gurrola Sandra M converted options into 437 shares and covered exercise/tax liability with 180 shares, increasing direct ownership by 28% to 1,185 units (SEC Form 4)4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Cicala Peter4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Bristol James Arthur4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
- SEC Form 4 filed by Gurrola Sandra M4 - Eterna Therapeutics Inc. (0000748592) (Issuer)